Seroreactivities against Saccharomyces cerevisiae and Mycobacterium avium subsp. paratuberculosis p35 and p36 Antigens in Crohn's disease patients

Digestive Diseases and Sciences

Volumn 47, Issue 9, 2002, Pages 2079-2081

  Shafran, Ira ^a   Piromalli, Christopher ^b   Decker, Jonathan W ^a   Sandoval, Javier ^a   Naser, Saleh A ^a   El Zaatari, Fouad A K ^c  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b FLORIDA HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

ASCA; Crohn's disease; M. paratuberculosis; Serologic markers

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PROTEIN P 36; PROTEIN P35; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; HUMAN; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SEROLOGY; VALIDATION PROCESS;

ANTIBODIES, BACTERIAL; ANTIBODIES, FUNGAL; CROHN DISEASE; HUMANS; MYCOBACTERIUM PARATUBERCULOSIS; SACCHAROMYCES CEREVISIAE; SEROLOGIC TESTS;

EID: 0036712128     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019685131692     Document Type: Article

References (15)

1. Long-term follow-up of patients with Crohn's disease: Relationship between the clinical pattern and prognosis
2. Current management of inflammatory bowel disease
3. Assessment of inflammatory activity in Crohn's disease
4. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease
5. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease
6. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role
7. Clinical evaluation of a new immunodiagnostic assay system for inflammatory bowel disease
8. The utility of ANCA and ASCA in inflammatory bowl disease
9. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define clinical subgroup
10. Marker antibody expression stratifies Crohn's disease into immunologically homogenous subgroup with distinct clinical characteristics
11. Identification and characterization of Mycobacterium paratuberculosis recombinant clones expressed in E. coli
12. Etiology of Crohn's disease: The role of Mycobacterium avium subspecies paratuberculosis
13. Specific seroreactivity of Crohn's disease patients against P35 and P36 antigens of M. avium subsp. paratuberculosis
14. Mycobacterium avium subs. paratuberculosis in Crohn's disease is serologically positive
15. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease